ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Healthy Males

In brief

The purpose of this research study is to determine how much male hormone, testosterone, is necessary to maintain sperm production in the testis. This knowledge will be used to help in the development of a safe male hormonal contraception. Specific Aims: 1. to determine if ketoconazole plus acyline will suppress intratesticular testosterone(ITT) to a greater degree than acyline alone. 2. to determine if dutasteride plus acyline will suppress intratesticular dihydrotestosterone (IT-DHT) to a greater degree than acyline alone. 3. to determine if anastrazole plus acyline will suppress intratesticular estradiol(IT-E2) to a greater degree than acyline alone.

Key facts

Study ID

NCT01215292

Run by

University of Washington

People needed

46

Starts

2011-01-01

Expected to finish

2012-03-01

Last updated by the study team

2014-03-31

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Males age 18-50
• Normal serum testosterone, LH and FSH
• prostate-specific antigen (PSA) < 4.0
• Agrees not to donate blood or participate in another research study during the study
• Informed consent
• Able to understand and comply with protocol requirements, instructions and protocol-stated restrictions
• In general good health based on normal screening evaluation (consisting of a medical history, physical exam, normal serum chemistry and hematology)
• Must be willing to use a reliable form of contraception during the study

You may not qualify if…

• Poor general health, with clinically significant abnormal blood results
• Participation in a long-term male contraceptive study within the past three months
• Participation in long-term contraceptive or drug study within the past 3 months
• History of or current liver disease
• Current use of terfenadine, astemizole, cisapride, budesonide, felodipine, fluticasone, lovastatin, midazolam, sildenafil, or vardenafil
• History of testicular, prostate, or scrotal surgery/trauma or genital abnormal exam
• BMI > 32
• History of sleep apnea and/or major psychiatric problems
• Chronic pain syndrome
• History of testosterone or anabolic steroid abuse currently or in the past
• Known bleeding disorder or current use of anticoagulation
• History of or current skin disorder that will interfere with testosterone gel
• Unwilling to adhere to protocol-stated restrictions while in the study

Where it is running

• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.